Note: Ingredients listed on restricted chemical lists
EC/CAS
238-878-4/14808-60-7
Name of the chemical
Silica, crystalline
Concentration
10-<20%
EC/CAS
209-136-7/556-67-2
Name of the chemical
D4
Concentration
N/A
General Information
Revision date
2021-10-13
Product name
BLUESIL RTV 3325
1.2.1 Relevant identified uses
Molding diverse objects
1.2.2. Uses advised against
None known
supplier name
Elkem Silicones (UK) Ltd
Manufacturer Name
Elkem Silicones France SAS
Emergency telephone
CHEMTREC UK (24h) +(44)-870-8200418 / National
Icons in SDS
Company Information
company name
Elkem Silicones (UK) Ltd
e-mail address of the competent person responsible for the Safety Data Sheet
fds.sil@elkem.com
GHS Information
Signal word
Danger
Hazard Codes
Hazard statements (CLP)
H372
Hazard statements
Code
Statements
H372
Causes damage to organs through prolonged or repeated exposure
Section 2
2.1 Classification of the substance or mixture
The product has been classified according to the legislation in force.
EU Classification
Regulation (EC) No 1272/2008 as amended
Health hazards
Specific Target Organ Toxicity - Category 1 H372: Causes damage to organs through Repeated Exposure prolonged or repeated exposure. Inhalation: Quartz/cristobalite : When encapsulated in a polymer, is not expected to pose a health hazard when processed under normal conditions of use. Although classified according to EC criteria, this product is exempt from labelling according to article 23 and Annex 1 (section 1.3.4.1) of regulation (CE) n°1272/2008. Eye contact: No specific symptoms noted. Skin contact: No specific symptoms noted. Ingestion: No specific symptoms noted.
Supplemental label elements
EUH210: Safety data sheet available on request.
Physical hazards
No specific recommendations.
Other Health Effects
No other information noted.
Environmental hazards
No hazard identified as the maximum bioavailable concentration of Octamethylcyclotetrasiloxane (D4) is lower than the classification cut-off value (see Section 12 of this SDS). endocrine disrupting properties according to REACH Article 57(f) or Commission Delegated regulation (EU) 2017/2100 or Commission Regulation (EU) 2018/605 at levels of 0.1% or higher.
Results of PBT and vPvB assessment
This substance/mixture contains components considered to be either persistent, bioaccumulative and toxic (PBT), or very persistent and very bioaccumulative (vPvB). Endocrine Disruption - The substance/mixture does not contain components considered to have Health: endocrine disrupting properties according to REACH Article 57(f) or Commission Delegated regulation (EU) 2017/2100 or Commission Regulation (EU) 2018/605 at levels of 0.1% or higher. Endocrine Disruption - The substance/mixture does not contain components considered to have
Other hazards
No other information noted.
